Dr Tarek Bismar
Position:
- Associate Professor, Pathology and Laboratory Medicine, Oncology, Biochemistry & Molecular Biology, University of Calgary
- Affiliate, Department of Oncology, McGill University
- Affiliate, Prostate Cancer Canada-Bio Network
- Member, International Society of Urological Pathology
- Member, Prostate Cancer BioResearch Network
- Member, United States and Canadian Academy of Pathology
- Member, Canadian Association of Pathologists
Biography:
Dr Bismar performed his medical studies in Syria, where he received his MD from Damascus University. He continued his postgraduate education at several US universities, including Washington University-St. Louis, Wayne State University in Michigan and Harvard University in Massachusetts. Dr Bismar specialized in pathology at Washington University in St. Louis. During his studies, he decided to continue his training in urological pathology and start his own prostate cancer research program. In addition to Dr Bismar's current role, he also supervises two post-doctorate candidates in the field of pathology. Dr Bismar has received the also received the PCF Young Investigator Award, and the Junior I Scientist Award from the Fonds de la Recherche en Santé du Québec. His work can be found in 38 publications and book chapters. He is also a reviewer for scientific journals such as Cancer Research , Clinical Cancer Research and Cancer .
Current Areas of Collaboration: Biomarkers of Aggressive and Indolent Prostate Cancer.
FISH, aCGH, alterations in chromosomes, alternative treatment, behaviour, biomarkers, cancer initiation, chemoprevention, clinical, exogenous factors, gene expression, genes/genetic polymorphisms, marker discovery, metastases, model systems, nutrition, oncogenes and tumour suppressor genes, oncology, pathology, proteomics, surveillance, systemic therapies, technology development.
